Parkinnova Therapeutics

Amsterdam, The Netherlands

Parkinnova Therapeutics is dedicated to developing innovative and targeted therapies for Parkinson's disease.

$398K raised

Apr 2025

Seed

Health Care Medical Pharmaceutical

Top Investors

Innovatiefonds Noord-Holland

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Parkinnova Therapeutics

How much funding has Parkinnova Therapeutics raised?

Parkinnova Therapeutics has raised $398K in total funding. The most recent round was Seed. The last funding was announced in April 2025.

Who are Parkinnova Therapeutics's investors?

Parkinnova Therapeutics's investors include Innovatiefonds Noord-Holland.

Where is Parkinnova Therapeutics headquartered?

Parkinnova Therapeutics is headquartered in Amsterdam, The Netherlands.

What does Parkinnova Therapeutics do?

Parkinnova Therapeutics is dedicated to developing innovative and targeted therapies for Parkinson's disease.

What stage is Parkinnova Therapeutics at?

Parkinnova Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 30, 2025.

MLA

"Parkinnova Therapeutics — Funding & Investors." VCBacked, April 30, 2025, https://www.vcbacked.co/company/parkinnova-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2025). Parkinnova Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/parkinnova-therapeutics

Wikipedia (cite web)

{{cite web |title=Parkinnova Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/parkinnova-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 30, 2025.